Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Shares Issued (2017 - 2024)

Nutex Health's Shares Issued history spans 7 years, with the latest figure at -$1000.0 for Q3 2024.

  • For Q3 2024, Shares Issued changed N/A year-over-year to -$1000.0; the TTM value through Jun 2025 reached -$1000.0, down 100.01%, while the annual FY2024 figure was $9.2 million, N/A changed from the prior year.
  • Shares Issued for Q3 2024 was -$1000.0 at Nutex Health, down from $9.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $9.2 million in Q1 2024 and bottomed at -$1.9 million in Q4 2023.
  • The 4-year median for Shares Issued is $153424.0 (2021), against an average of $1.4 million.
  • The largest annual shift saw Shares Issued skyrocketed 7500.0% in 2023 before it skyrocketed 384.37% in 2024.
  • A 4-year view of Shares Issued shows it stood at $153424.0 in 2021, then surged by 304.09% to $619974.0 in 2022, then crashed by 406.46% to -$1.9 million in 2023, then soared by 99.95% to -$1000.0 in 2024.
  • Per Business Quant, the three most recent readings for NUTX's Shares Issued are -$1000.0 (Q3 2024), $9.2 million (Q1 2024), and -$1.9 million (Q4 2023).